JonathanDKurtisMD
Pathology • Providence, RIBlood Banking & Transfusion Medicine, Transplantation Immunology, Clinical Pathology
Professor, Pathology and Lab Medicine, Brown University Program in Medicine
Are you Dr. Kurtis?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 24 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
593 Eddy St
Department Of Pathology Apc-12
Providence, RI 02903Phone+1 401-444-7241Fax+1 401-444-8514
Summary
- Dr. Jonathan Kurtis, MD is a board certified pathologist in Providence, Rhode Island. He is currently licensed to practice medicine in Rhode Island and Pennsylvania. He is affiliated with Rhode Island Hospital and Miriam Hospital.
Education & Training
University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 1997 - 2000
The Warren Alpert Medical School of Brown UniversityClass of 1996
Certifications & Licensure
RI State Medical License 2000 - 2026
PA State Medical License 1998 - 2000- American Board of Pathology Clinical Pathology
- American Board of Pathology Blood Banking/Transfusion Medicine
Publications & Presentations
PubMed
- 55 citationsEfficacy and safety of praziquantel for the treatment of human schistosomiasis during pregnancy: a phase 2, randomised, double-blind, placebo-controlled trialRemigio M. Olveda, Luz P. Acosta, Veronica Tallo, Palmera Baltazar, Jenny Lind S Lesiguez
The Lancet. Infectious Diseases. 2016-02-01 - 53 citationsAnti-PfGARP activates programmed cell death of parasites and reduces severe malariaDipak Kumar Raj, Alok Das Mohapatra, Anup Jnawali, Jenna Zuromski, Ambrish Jha
Nature. 2020-04-22 - 99 citationsDecreased susceptibility to Plasmodium falciparum infection in pregnant women with iron deficiency.Edward Kabyemela, Michal Fried, Jonathan D. Kurtis, Theonest K. Mutabingwa, Patrick E. Duffy
The Journal of Infectious Diseases. 2008-07-15
Press Mentions
Ocean Biomedical Prices IPO at $7.00-$9.00 Per Share (OCEA)July 26th, 2021
Research Reveals a New Malaria Vaccine CandidateApril 22nd, 2020
